Twelve Health Care ETFs Trading Near 52-Week Highs

PowerShares S&P SmallCap Health Care (NYSE: PSCH) is up nearly 22% year to date. The investment seeks to replicate the S&P SmallCap 600 Capped Health Care index, which is comprised of common stocks of U.S. health care companies. Top holdings include Regeneron Pharmaceuticals (NASDAQ: REGN), Amerigroup (NYSE: AGP) and Cooper Companies (NYSE: COO).SPDR S&P Biotech (NYSE: XBI) is up more than 19% since the beginning of the year. The underlying index represents the biotechnology subindustry portion of the S&P Total Market index. Top holdings include Theravance (NASDAQ: THRX) and Savient Pharmaceuticals (NASDAQ: SVNT).PowerShares Dynamic Healthcare (NYSE: PTH) is up nearly 19% year to date. The underlying index consists of U.S. companies engaged in providing health care-related products and services, including biotechnology, pharmaceuticals, medical technology, supplies and facilities. Top holdings include Biogen Idec (NASDAQ: BIIB), Humana (NYSE: HUM) and St. Jude Medical (NYSE: STJ). First Trust Health Care AlphaDEX (NYSE: FXH) is up more than 18% year to date. The investment seeks results that correspond generally to the price and yield of the StrataQuant Health Care Index. Top holdings include Regeneron Pharmaceuticals (NASDAQ: REGN), Endo Pharmaceuticals (NASDAQ: ENDP) and UnitedHealth Group (NYSE: UNH). SPDR S&P Health Care Equipment (NYSE: XHE) is about 17% higher since the beginning of the year. The fund tracks the total return performance of the S&P Health Care Equipment Select Industry Index. Top holdings include Mako Surgical (NASDAQ: MAKO) and NuVasive (NASDAQ: NUVA).Rydex S&P Equal Weight Health Care (NYSE: RYH) is up nearly 17% since the beginning of the year. The fund uses a passive management strategy to track the performance of the underlying index. Top holdings include Cephalon (NASDAQ: CEPH), MedcoHealth Solutions (NYSE: MHS) and Biogen Idec (NASDAQ: BIIB).iShares Nasdaq Biotechnology (NASDAQ: IBB) is up more than 14% year to date. The fund normally invests at least 90% of assets in securities of Nasdaq-listed companies that are classified as either biotechnology or pharmaceuticals. Top holdings include Amgen (NASDAQ: AMGN), Teva Pharmaceutical (NASDAQ: TEVA) and Celgene (NASDAQ: CELG).Vanguard Health Care ETF (NYSE: VHT) is about 14% higher than at the beginning of the year. The fund invests substantially all of its assets in the stocks that make up the MSCI U.S. Investable Market Health Care 25/50 Index. Top holdings include Johnson & Johnson (NYSE: JNJ), Pfizer (NYSE: PFE) and Merck (NYSE: MRK).iShares S&P Global Healthcare Sector Index Fund (NYSE: IXJ) is up nearly 14% year to date. The fund generally invests at least 90% of its assets in securities of health care providers, biotechnology companies and manufacturers of medical supplies, advanced medical devices and pharmaceuticals. Top holdings include Johnson & Johnson (NYSE: JNJ), Pfizer (NYSE: PFE) and Merck (NYSE: MRK).PowerShares Dynamic Pharmaceuticals (NYSE: PJP) is up nearly 14% year to date. The investment seeks to replicate the Dynamic Pharmaceuticals Intellidex index, which includes companies engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. Top holdings include Eli Lilly (NYSE: LLY), Merck (NYSE: MRK) and Amgen (NASDAQ: AMGN). iShares Dow Jones U.S. Healthcare (NYSE: IYH) is nearly 14% higher than at the beginning of year. The fund invests at least 90% of its assets in securities of health care equipment and services, pharmaceutical and biotechnology companies. Top holdings include Johnson & Johnson (NYSE: JNJ), Pfizer (NYSE: PFE) and Merck (NYSE: MRK).SPDR S&P Pharmaceuticals (NYSE: XPH) is up about 13% since the beginning of the year. The underlying index represents the pharmaceuticals subindustry portion of the S&P Total Market index. Top holdings include Questcor Pharmaceuticals (NASDAQ: QCOR), VIVUS (NASDAQ: VVUS) and Valeant Pharmaceutical (NYSE: VRX).